# DecImmune Therapeutics (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/decimmune-therapeutics-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 82 |
| Citations | 16,399 |
| City | Cambridge |
| Country | US |
| Description | DecImmune Therapeutics (United States) is a research organisation in Cambridge, US. OpenAlex records 182 works and 16,399 citations for it. 147 researchers list it as their most recent affiliation. |
| Homepage | https://www.decimmune.com/index.html |
| OpenAlex ID | https://openalex.org/I4210108096 |
| Region | Massachusetts |
| Researchers | 147 |
| ROR ID | https://ror.org/01y9tmc90 |
| Type | company |
| Works | 182 |

## University papers

- [Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis](https://scholariq.org/papers/glycine-decarboxylase-activity-drives-non-small-cell-lung-cancer-tumor/)
- [Genomic landscape of lung adenocarcinoma in East Asians](https://scholariq.org/papers/genomic-landscape-of-lung-adenocarcinoma-in-east-asians/)
- [Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia](https://scholariq.org/papers/requirement-of-src-kinases-lyn-hck-and-fgr-for-bcr-abl1-induced-b-lymphoblastic/)
- [Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression](https://scholariq.org/papers/tumour-initiating-cell-specific-mir-1246-and-mir-1290-expression-converge-to/)

## University top topics

Showing 8 of 25.

- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Hearing, Cochlea, Tinnitus, Genetics](https://scholariq.org/topics/hearing-cochlea-tinnitus-genetics/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Hearing Loss and Rehabilitation](https://scholariq.org/topics/hearing-loss-and-rehabilitation/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Vestibular and auditory disorders](https://scholariq.org/topics/vestibular-and-auditory-disorders/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.